Spikevax (Moderna mRNA-1273 COVID-19 vaccine) living meta-analysis of clinical studies

demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only

	COVID-19 severe or critically

	COVID-19 prophylaxis (excluding children)
Spikevax (Moderna mRNA-1273 COVID-19 vaccine)	COVE Moderna/NIH phase 3 ...

4888	study 101 dose finding, 2020	2	31	0	excluded	not a RCT	risk of bias not avaialble
6054	Moderna preclinical (Corbett), 2020	2	1	0	excluded		risk of bias not avaialble
6365	Moderna study 201 100µg, 2020	1	1	0			risk of bias not avaialble
6935	Benotmane, 2021	1	32	0		not a RCT	risk of bias not avaialble
6949	Pawlowski, 2021	1	13	0		not a RCT	risk of bias not avaialble
8159	Moderna delta VOC press realease, 2021	1	13	0		not a RCT	risk of bias not avaialble
8507	Klein, 2021	1	13	4		not a RCT	high risk of bias
9158	Husby (Moderna), 2021	1	12	0		not a RCT	risk of bias not avaialble
9209	Southern California (Tseng) - omicron, 2022	1	20	0		not a RCT	risk of bias not avaialble
9244	Richardson, 2022	0	0	0	selection pending
9407	Southern California (Tseng) - delta, 2022	1	20	0		not a RCT	risk of bias not avaialble
9448	Chalkias, 2022	0	30	0	selection pending